GLP-1 Weight Loss: What Happens to Body Composition?

A pound lost isn't a pound lost. Whether that pound comes from fat, muscle, water, or bone matters enormously for your long-term health and function, and it's the piece of the GLP-1 story the scale alone can never tell you. Here's what detailed body composition research actually shows.

Why Body Composition Matters More Than the Number on the Scale

Two people can lose the exact same 30 pounds and end up in meaningfully different places health-wise, depending on what that 30 pounds was made of. Someone who loses mostly fat while preserving muscle typically sees improved strength, metabolic health, and physical function. Someone who loses a large share of that same weight as muscle may see the scale number improve while their strength, resting metabolic rate, and physical resilience decline, even at a lower body weight.

This is why obesity medicine has increasingly moved toward measuring body composition specifically, through tools like DEXA scans, rather than relying on body weight or BMI alone, when evaluating how well a weight-loss treatment is actually working for an individual patient.

The Fat-to-Muscle Ratio: What Studies Show

Body composition sub-studies within the major semaglutide and tirzepatide trials, which used DEXA scanning on a subset of participants, generally found that roughly 60% to 75% of total weight lost was fat mass, with the remaining 25% to 40% coming from lean soft tissue, primarily muscle. This ratio is generally considered less favorable than the ratio typically seen with resistance-training-focused weight loss in research settings, where lean mass loss can be kept to a smaller share of the total, but is roughly comparable to, or somewhat worse than, ratios seen with other rapid weight-loss methods like very-low-calorie diets or bariatric surgery without dedicated exercise intervention.

For a deeper look at the specific research behind the muscle-loss half of this equation, including which drugs and patient groups are most affected, see GLP-1 drugs and muscle loss.

Not All Fat Loss Is Equal Either

Just as not all weight loss is equal, not all fat loss is equal either. Visceral fat, the fat stored around internal organs in the abdominal cavity, is considered more metabolically harmful than subcutaneous fat, the fat stored just under the skin, since visceral fat is more strongly linked to insulin resistance, inflammation, and cardiovascular risk.

Imaging-based body composition research on GLP-1 drugs has found that visceral fat tends to decrease disproportionately compared with overall fat loss, meaning a larger relative share of the fat lost tends to come from this more harmful visceral depot rather than subcutaneous fat. This is considered a favorable pattern from a metabolic health standpoint, independent of the total weight-loss percentage, and likely contributes to the blood sugar and cardiovascular improvements covered in how GLP-1 drugs affect blood sugar and can GLP-1 drugs affect blood pressure.

Combining resistance training with a GLP-1 drug appears to improve the fat-to-muscle ratio of total weight lost.

What About Bone Density

Bone health is a newer and less thoroughly settled area of GLP-1 body composition research compared with fat and muscle. Some studies have found small reductions in bone mineral density accompanying significant weight loss on these drugs, which researchers attribute partly to reduced mechanical loading on bones as body weight decreases, since bones respond to the physical stress of carrying body weight by maintaining density, and partly to possible direct effects of rapid weight loss on bone metabolism more broadly, a pattern also observed with other rapid weight-loss methods including bariatric surgery.

This remains an area of active research rather than a fully settled question, and the clinical significance of the reductions observed so far, meaning whether they meaningfully increase fracture risk for most patients, isn't yet clearly established. Weight-bearing exercise, which is also the resistance training recommended for muscle preservation, is generally considered protective for bone density as well, giving another practical reason to prioritize it during treatment.

How to Track Your Own Body Composition

If you want to understand what's happening to your own body composition rather than relying on trial averages, a few options exist at different levels of accessibility and precision.

For most people, a combination of periodic waist circumference measurement and tracking strength on a few basic exercises gives a reasonably practical, free way to monitor whether your body composition trend looks favorable, without needing regular access to a DEXA scanner.

Why This Matters More Than the Number on the Scale

If there's one takeaway to carry from this entire body composition picture, it's that the number on a bathroom scale, while easy to track, is a genuinely incomplete measure of how well treatment is going for you personally. Two people who each lose 20 pounds over the same number of months could be in very different places: one with strength and function improving alongside a smaller waistline, the other with a smaller number on the scale but declining strength and stamina, and both would look identical if you only looked at their weight-loss chart.

Age and Sex Differences in Body Composition Response

Some body composition research suggests that age and sex may influence the specific fat-to-muscle ratio of weight lost, with older adults generally showing a somewhat less favorable ratio, meaning a higher proportion of lean mass loss relative to fat loss, than younger adults losing comparable total weight, likely reflecting the natural age-related decline in baseline muscle mass and muscle-building capacity that occurs independent of any medication.

This doesn't mean older adults shouldn't pursue GLP-1 treatment when it's otherwise appropriate; it means the case for prioritizing resistance training and adequate protein intake, covered in detail in GLP-1 drugs and exercise and GLP-1 drugs and protein intake, is if anything stronger for older patients specifically, given their reduced margin for lean mass loss without meaningful functional consequences.

Putting It All Together: A Realistic Expectation

Based on the available research, a realistic expectation for body composition changes on a GLP-1 drug looks something like this: the majority, roughly 60% to 75%, of weight lost will be fat, with a favorable tendency toward disproportionate loss of harmful visceral fat specifically. A meaningful minority, roughly 25% to 40%, will be lean tissue, primarily muscle, which can be reduced through resistance training and adequate protein intake but likely won't be eliminated entirely even with a good effort on both fronts. Bone density effects are a smaller, less certain, but real consideration, particularly for older adults or anyone with pre-existing bone health concerns.

None of this is a reason to avoid treatment if it's appropriate for you; it's a reason to actively manage the modifiable parts of the equation, exercise and protein intake specifically, rather than assuming the medication alone will produce an optimal outcome without any additional effort on your part.

Frequently Asked Questions

What percentage of weight lost on Ozempic or Zepbound is fat versus muscle?

Body composition sub-studies generally find roughly 60% to 75% of total weight lost is fat mass, with the remaining 25% to 40% being lean soft tissue, primarily muscle.

Does GLP-1 weight loss target harmful visceral fat specifically?

Imaging research suggests visceral fat, the metabolically harmful fat around internal organs, decreases disproportionately compared with overall fat loss, which is considered a favorable pattern for metabolic health.

Do GLP-1 drugs affect bone density?

Some studies have found small reductions in bone mineral density accompanying significant weight loss, though the clinical significance for fracture risk isn't yet fully established. This remains an area of ongoing research.

How can I track my own body composition without a DEXA scan?

Waist circumference measurement (a practical proxy for visceral fat) and tracking strength on basic resistance exercises (a proxy for muscle preservation) offer free, accessible ways to monitor your trend without specialized equipment.

Sources and References

1. PMC — Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series, 2026
2. Jastreboff et al. — Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine, 2022
3. Journal of Bone and Mineral Research — Bone density changes with GLP-1 receptor agonist-induced weight loss, ongoing research literature